UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 27, 2013

Accession Number:	0001144204-13-036401
Submission Type:	POS AM
CIK: 0001053369 Company Name: ELITE PHARMACEUTICALS INC /NV/ File Number: 333-188139